用于骨组织工程的羟基丁酸-戊酸共聚物/生物活性玻璃复合多孔支架材料

研究了用于骨组织工程的复合型羟基丁酸-戊酸共聚物／溶胶-凝胶生物活性玻璃多孔支架材料，采用溶液浇注沥滤法制备了任意形状的三维连通多孔结构支架，并进行三维结构表征和显微形貌观察；通过对成型条件的调节，可控制支架的孔径和孔隙率；在模拟生理体液中进行复合支架材料的生物活性测试。研究表明，通过控制致孔剂用量、尺寸大小和分散，得到的支架材料呈三维连通开孔结构，且孔隙分布均匀、孔隙率达90％以上；扫描电镜观察结果显示，羟基丁酸-戊酸共聚物与生物活性玻璃良好相容，后者粘附在支架孔壁上；支架在模拟生理体液中浸泡后发现生物活性玻璃表面有羟基碳酸磷灰石多晶体生成，表明复合支架仍保持了BG的生物活性。     

冷冻抽提相分离法制备聚乳酸多孔支架

为了制备结构和性能满足骨组织工程支架要求的聚乳酸(PLA)多孔支架材料,采用冷冻抽提相分离法,以1,4-二氧六环和水为混合溶剂,聚乙二醇(PEG)为致孔剂,制得一系列PLA多孔支架,探讨了溶剂组成、PLA浓度、PEG添加量对PLA多孔支架结构和性能的影响,结果表明添加PEG有利于形成多孔三维支架,随着PEG含量的增加,...     

超临界CO2中制备聚乳酸/羟基磷灰石复合支架材料

利用盐析/超临界CO2复合方法制备了一系列的PDLLA/HA三维多孔支架材料.利用这种方法可以避免使用有机溶剂、较高温度和降低常规气体发泡法所需的较长时间.制备的三维多孔支架的孔隙率最高达91%,孔与孔之间相互连通,孔分布均匀,孔径大小为100～300μm,抗压强度明显增加.详细研究了CO2压力、温度、浸润时间以及致孔剂含量等条件的变化对复合材料形貌和孔隙率的影响.     

软骨细胞在聚乳酸支架中的体外生长行为

采用明胶和氯化钠颗粒作为致孔剂,使用溶剂浇铸／颗粒沥滤法制备了高孔隙率、孔间连通和高机械性能的聚乳酸支架,采用软骨细胞体外培养研究了这两种多孔支架对细胞生长性能的影响．结果表明,软骨细胞在以明胶颗粒为致孔剂制备的多孔支架中的相对数量和GAG的分泌量更多,细胞的活性更高。     

P(VAc-co-TAIC)大孔树脂颗粒的制备及声学性能

采用悬浮聚合制备了醋酸乙烯酯-三烯丙基异氰酸酯共聚物大孔树脂颗粒,研究了交联剂和致孔剂用量对大孔树脂颗粒密度、孔体积和孔隙率的影响,结果表明:树脂的孔体积和孔隙率随致孔剂的用量及树脂颗粒直径的增加而增大.空气声吸收性能测试结果表明:在PU/EP共混物基体中加入大孔树脂颗粒能增强其吸声效果;水声性能测试表明:在PU/EP...     

造孔剂对新型医用多孔Ti-14Mo-2.1Ta-0.9Nb-7Zr合金组织性能的影响

合金多孔化是有效降低材料弹性模量的方式之一,采用添加造孔剂的元素粉末冶金法制备了新型医用多孔Ti-14Mo-2.1Ta-0.9Nb-7Zr合金,通过扫描电镜、阿基米德法、X射线衍射和压缩力学性能测试的方法研究了不同造孔剂用量和粒径尺寸对合金形貌特征、孔隙率、物相组成及力学性能的影响规律。结果表明:该方法制备所得多孔Ti-14Mo-2.1Ta-0.9Nb-7Zr合金为近β型钛合金;随着造孔剂用量增加,平均孔径无变化,孔隙率呈线性增长,弹性模量和抗压强度减小,其中弹性模量的变化满足线性关系;随着造孔剂粒径尺寸增加,平均孔径增大而孔隙率基本不变,抗压强度和弹性模量减小;添加20%(质量分数)粒径尺寸为125~200μm的NH4HCO3造孔剂制备多孔Ti-14Mo-2.1Ta-0.9Nb-7Zr合金,于1300℃烧结4h孔隙率达到38.9%并含有贯穿孔结构,抗压强度达到405 MPa,而弹性模量为9.19GPa,能满足医用植入材料的要求。     

新型可降解钙磷骨水泥多孔支架研究

采用一种特殊的方法制备了孔径、孔隙率和孔形状可控的多孔羟基磷灰石骨水泥支架. 材料的抗压强度可达4MPa, 孔隙率可达70%, 孔与孔之间互相贯通, 大孔壁富含微孔. 细胞在材料表面黏附铺展且增殖良好, 体外模拟实验显示材料的降解速度随孔隙率的增加和Ca/P比的降低而加快, 多孔支架有优良的生物降解性和生物相容性. 该材料可用于修复骨组织缺损和作为支架材料用于组织工程.     

聚L-乳酸/β-磷酸三钙复合骨支架材料成型工艺优化研究

利用溶剂自扩散-模压成型-粒子沥滤法制备聚L-乳酸(PLLA)/β-磷酸三钙(β-TCP)复合多孔支架材料,采用正交设计对成型工艺进行了优化,对支架进行了形貌观察、力学强度和孔隙率大小测试.结果表明:当PLLA∶β-TCP=1∶2,成型压力5 MPa,致孔剂粒径125～400 μm,用量80%(wt)时,制备的支架材料孔结构三维贯通,抗压强度为4.45 MPa、孔隙率为60.7%,满足骨组织工程支架材料要求.     

聚己内酯多级孔径支架的相分离/盐析复合工艺研究

采用相分离和盐析复合工艺,通过改变冷却温度、溶液浓度、溶剂/水比例、造孔剂用量等工艺制备聚己内酯多孔支架,通过扫描电镜观察支架形貌,采用压汞仪测量支架孔隙率及孔径,研究各工艺条件对支架多级孔径结构的影响.研究表明冷却温度-70℃、PCL溶液浓度10%、溶剂/水比例95/5、80%质量含量的粒径100～200μm NaCl造孔剂为最佳实验条件,可制备出具有100～350μm大孔、5～30μm小孔及＜10nm微孔的聚己内酯复合多级孔径支架,孔隙率高,连通性好,可应用于骨组织工程支架.     

聚L-乳酸/β-磷酸三钙复合骨支架材料成型工艺优化研究

利用溶剂自扩散-模压成型-粒子沥滤法制备聚L-乳酸(PLLA)/β-磷酸三钙(β-TCP)复合多孔支架材料,采用正交设计对成型工艺进行了优化,对支架进行了形貌观察、力学强度和孔隙率大小测试。结果表明:当PLLA:β-TCP=1:2,成型压力5MPa,致孔剂粒径125～400μm,用量80% (wt)时,制备的支架材料孔结构三维贯通,抗压强度为4．45MPa、孔隙率为60．7%,满足骨组织工程支架材料要求。     

Fabrication of three dimensional polymeric scaffolds with spherical pores

This paper reports polymeric scaffolds with spherical internal macropores and relatively large external dimension. Paraffin spheres with the diameter of several hundred microns were prepared by a suspension technique. Particulate leaching technique based on this kind of spherical porogens was combined with room-temperature compression molding technique to fabricate biodegradable poly(D,L-lactic-co-glycolic acid) (PLGA) porous scaffolds potentially for tissue engineering or in situ tissue induction. The scaffolds exhibited ordered macropores with good pore interconnectivity. The porosity ranged from 80 to 97% adjusted simply by varying porogen content. The foams with porosity around 90% have compressive modulus over 3 MPa and compressive strength over 0.2 MPa. As preliminary cell experiments with 3T3 fibroblasts cultured on the porous scaffolds indicate, the processing procedure of the scaffolds has not brought with problem in cytotoxicity.     

Biodegradable polycaprolactone scaffold with controlled porosity obtained by modified particle-leaching technique

Scaffold with controlled porosity constitute a cornerstone in tissue engineering, as a physical support for cell adhesion and growth. In this work, scaffolds of polycaprolactone were synthesized by a modified particle leaching method in order to control porosity and pore interconnectivity; the aim is to observe their influence on the mechanical properties and, in the future, on cell adhesion and proliferation rates. Low molecular weight PEMA beads with an average size of 200 μm were sintered with various compression rates in order to obtain the templates (negatives of the scaffolds). Then the melt polycaprolactone was injected into the porous template under nitrogen pressure in a custom made device. After cooling and solidifying of the melt polymer, the porogen was removed by selective dissolution in ethanol. The porosity and morphology of the scaffold were studied as well as the mechanical properties. Porosities from 60% to 85% were reached; it was found that pore interconnectivity logically increases with increasing porosity, and that mechanical strength decreases with increasing porosity. Because of their interesting properties and interconnected structure, these scaffolds are expected to find useful applications as a cartilage or bone repair material.     

Preparation of 3-D regenerated fibroin scaffolds with freeze drying method and freeze drying/foaming technique

Although three-dimensional fibroin scaffolds have been prepared with freeze drying method, the porosity and pore sizes still can not satisfy the requirement of tissue engineering. In this article, fibroin porous scaffold with high porosity and > 100μm diameter interconnected pores was firstly prepared with freeze drying method through adjusting fibroin concentration. The morphology of different scaffolds lyophilized from different fibroin concentration was observed by SEM. A novel freeze drying improved method, freeze drying/foaming technique, was also devised to prepare fibroin scaffolds at different fibroin concentrations. Using the said method, the porosity and pore size of fibroin scaffolds prepared from 12% concentration were 85.8 ± 4% and 109 ± 20 μm respectively with yield strength up to 450 ± 6 KPa while the porosity and pore size of fibroin scaffolds prepared from 8% concentration were 96.9 ± 3.6% and 120 ± 30 μm respectively with yield strength up to 30 ± 1 KPa. The freeze drying/foaming technique produced scaffolds with a useful combination of high yield strength, interconnected pores, and pore sizes greater than 100 μm in diameter. Through adjusting fibroin concentration and thawing time, the porosity, pore sizes and mechanical properties could be controlled to satisfy the different requirements of tissue engineering. The results suggested that fibroin scaffolds prepared with the above methods could be formed for utility in biomaterial application.     

The double porogen approach as a new technique for the fabrication of interconnected poly(L-lactic acid) and starch based biodegradable scaffolds

One of the most widely used fabrication methods of three dimensional porous scaffolds involves compression moulding of a polymer salt mixture, followed by salt leaching. However, the scaffolds prepared by this technique have typically limited interconnectivity. In this study, besides salt particles, an additional polymeric porogen, poly(ethylene oxide), PEO, was added to poly(L-lactic acid), PLLA, to enhance the interconnectivity of the scaffolds. Compression moulded specimens were quenched and put into water, where PEO crystallized and phase separated. Following the leaching of PEO fraction, the permeability and interconnectivity among the macropores formed by salt leaching could be observed. The porosities obtained in the prepared scaffolds were between 76 to 86%. Moreover, the highest porosity of 86% was obtained with minimum fraction of total porogen. The water absorption of the porous scaffolds prepared with PEO could vary between 280 to 450% while water uptake of pure PLLA scaffolds was about 93%. The increase of interconnectivity induced by compounding PLLA with PEO could also be obtained in porous PLLA/starch blends and PLLA/hydroxyapatite composites demonstrating the versatility and wide applicability of this preparation protocol. The simplicity of this organic solvent free preparation procedure of three-dimensional porous scaffolds with high interconnectivity and high surface area to volume ratio holds a promise for several tissue engineering applications.     

Porous ceramic bone scaffolds for vascularized bone tissue regeneration

Hydroxyapatite scaffolds with a multi modal porosity designed for use in tissue engineering of vascularized bone graft substitutes were prepared by three dimensional printing. Depending on the ratio of coarse (mean particle size 50 microm) to fine powder (mean particle size 4 microm) in the powder granulate and the sintering temperature total porosity was varied from 30% to 64%. While macroscopic pore channels with a diameter of 1 mm were created by CAD design, porosity structure in the sintered solid phase was governed by the granulate structure of the printing powder. Scaffolds sintered at 1,250 degrees C were characterized by a bimodal pore structure with intragranular pores of 0.3-0.4 microm and intergranular pores of 20 microm whereas scaffolds sintered at 1,400 degrees C exhibit a monomodal porosity with a maximum of pore size distribution at 10-20 microm. For in-vivo testing, matrices were implanted subcutaneously in four male Lewis rats. Scaffolds with 50% porosity and an average pore size of approximately 18 microm were successfully transferred to rats and vascularized within 4 weeks.     

In Vitro Characterizations of PLLA/β-TCP Porous Matrix Materials and RMSC-PLLA-β-TCP Composite Scaffolds

To develop a novel degradable poly (L-lactic acid)/β-tricalcium phosphate (PLLA/β-TCP) bioactive materials for bone tissueengineering, β-TCP powder was produced by a new wet process. Porous scaffolds were prepared by three steps, i.e. solventcasting, compression molding and leaching stage. Factors influencing the compressive strength and the degradation behaviorof the porous scaffold, e.g. weight fraction of pore forming agent-sodium chloride (NaCl), weight ratio of PLLA: β-TCP,the particle size of β-TCP and the porosity, were discussed in details. Rat marrow stromal cells (RMSC) were incorporatedinto the composite by tissue engineering approach. Biological and osteogenesis potential of the composite scaffold weredetermined with MTT assay, alkaline phosphatase (ALP) activity and bone osteocalcin (OCN) content evaluation. Resultsshow that PLLA/β-TCP bioactive porous scaffold has good mechanical and pore structure with adjustable compressive strengthneeded for surgery. RMSCs seeding on porous PLLA/     

具有良好贯通性的颗粒造孔支架的制备及表征

支架孔隙贯通性的研究一直是多孔生物陶瓷的研究重点之一.采用石蜡球作为造孔剂, 在常规的颗粒造孔法制备多孔陶瓷支架的基础上,通过二甲苯处理以便在石蜡球间形成桥联结构, 以扩大颗粒间的接触面积,从而提高多孔陶瓷支架的孔隙贯通性. 借助扫描电镜(SEM)观察陶瓷支架的多孔结构,评价二甲苯处理石蜡球对陶瓷支架孔隙贯通性的改善效果; 采用密度法测定了陶瓷支架的孔隙率并计算其收缩率,并用成骨细胞评价陶瓷支架的细胞相容性. 结果表明,通过二甲苯的处理, 不仅改善了陶瓷支架孔隙的贯通性,而且提高了其孔隙率, 但孔隙率对陶瓷支架的收缩率无明显影响.细胞培养实验显示成骨细胞可进入多孔陶瓷支架内部, 并在材料表面正常生长,贯通性好的多孔陶瓷支架可为成骨细胞生长提供更充分的空间.     

浆料粘度对纳米羟基磷灰石/聚酰胺66复合支架孔结构与力学性能的影响

浆料粘度是热诱导相分离法制备支架材料的关键因素,采用不同粘度的纳米羟基磷灰石/聚酰胺66(n-HA/PA66)复合浆料制备了相应的n-HA/PA66多孔支架,并对不同粘度浆料制备支架材料的泡孔结构和力学性能等进行了对比研究。结果表明,浆料粘度对n-HA/PA66复合多孔支架的孔径、孔径分布、孔隙率、开孔率、力学强度等性能有显著的影响。随着浆料粘度的增大,制备支架的孔径、孔隙率、开孔率逐渐减小,而力学强度却逐渐增大。当浆料粘度为330Pa.s时,制备出的n-HA/PA66复合多孔支架综合性能最好,其孔径主要分布在200～500μm,平均孔径(324±67.1)μm,孔隙率为(75±1.6)%,开孔率为(59±2.5)%,抗压强度为(2.12±0.90)MPa,能够较好地满足骨组织工程支架材料对孔径、孔隙率和力学性能的要求。     

磷灰石-硅灰石/β-磷酸三钙复合多孔支架材料的制备和表征

以磷灰石-硅灰石玻璃陶瓷(AW)粉和β-磷酸三钙(β-TCP)粉为原料. 以硬脂酸为致孔剂. 经模压成型、1170℃烧结制备磷灰石-硅灰石/β-磷酸三钙复合多孔支架材料(AW/βTCP). 采用X射线衍射(XRD)、扫描电镜(SEM)、能谱(EDS)、诱导耦合等离子体原子发射光谱(ICP-AES)等方法分析支架的晶相组成、显微结构、物理性能、生物活性和降解性. 将大鼠骨髓间充质干细胞(rMSCs)与支架体外复合培养评价支架的生物相容性. 结果表明: 所制备的AW/β-TCP支架材料的抗压强度达14.3MPa. 孔隙率达66.9%. 孔径为100～700μm. 具有良好的生物相容性、生物活性和降解性. 可作为骨组织工程支架的候选材料.